Bibtex |
@araştırma makalesi { auvfd552122,
journal = {Ankara Üniversitesi Veteriner Fakültesi Dergisi},
issn = {1300-0861},
eissn = {1308-2817},
address = {},
publisher = {Ankara Üniversitesi},
year = {2019},
volume = {66},
number = {4},
pages = {385 - 389},
doi = {10.33988/auvfd.552122},
title = {Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease},
key = {cite},
author = {Çolakoğlu, Ekrem Çağatay and Alihosseini, Hadi and Haydardedeoğlu, Ali Evren}
} |
APA
|
Çolakoğlu, E. Ç.
, Alihosseini, H.
& Haydardedeoğlu, A. E.
(2019).
Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease
.
Ankara Üniversitesi Veteriner Fakültesi Dergisi
, 66 (4) ,
385-389 .
DOI: 10.33988/auvfd.552122 |
MLA
|
Çolakoğlu, E. Ç.
, Alihosseini, H.
, Haydardedeoğlu, A. E.
"Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease"
.
Ankara Üniversitesi Veteriner Fakültesi Dergisi 66 (2019
): 385-389 <http://vetjournal.ankara.edu.tr/tr/pub/issue/47708/552122>
|
Chicago
|
Çolakoğlu, E. Ç.
, Alihosseini, H.
, Haydardedeoğlu, A. E.
"Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease".
Ankara Üniversitesi Veteriner Fakültesi Dergisi 66 (2019
): 385-389 |
RIS |
TY - JOUR
T1 - Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease
AU - Ekrem ÇağatayÇolakoğlu, HadiAlihosseini, Ali EvrenHaydardedeoğlu
Y1 - 2019
PY - 2019
N1 - doi: 10.33988/auvfd.552122 DO - 10.33988/auvfd.552122 T2 - Ankara Üniversitesi Veteriner Fakültesi Dergisi
JF - Journal
JO - JOR
SP - 385
EP - 389
VL - 66
IS - 4
SN - 1300-0861-1308-2817
M3 - doi: 10.33988/auvfd.552122 UR - https://doi.org/10.33988/auvfd.552122 Y2 - 2019
ER -
|
EndNote |
%0 Ankara Üniversitesi Veteriner Fakültesi Dergisi Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease
%A Ekrem Çağatay Çolakoğlu
, Hadi Alihosseini
, Ali Evren Haydardedeoğlu
%T Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease
%D 2019
%J Ankara Üniversitesi Veteriner Fakültesi Dergisi
%P 1300-0861-1308-2817
%V 66
%N 4
%R doi: 10.33988/auvfd.552122 %U 10.33988/auvfd.552122 |
ISNAD |
Çolakoğlu, Ekrem Çağatay
, Alihosseini, Hadi
, Haydardedeoğlu, Ali Evren
.
"Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease".
Ankara Üniversitesi Veteriner Fakültesi Dergisi
66
/
4
(Eylül 2019):
385-389 . https://doi.org/10.33988/auvfd.552122 |
AMA |
Çolakoğlu E. Ç.
, Alihosseini H.
, Haydardedeoğlu A. E.
Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease.
Ankara Univ Vet Fak Derg.
2019;
66(4):
385-389. |
Vancouver |
Çolakoğlu E. Ç.
, Alihosseini H.
, Haydardedeoğlu A. E.
Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease.
Ankara Üniversitesi Veteriner Fakültesi Dergisi.
2019;
66(4):
385-389. |
IEEE |
E. Ç. Çolakoğlu
, H. Alihosseini
ve A. E. Haydardedeoğlu
,
"Clinical significance of pretreatment Ca-P solubility product in 47 cats with chronic kidney disease",
Ankara Üniversitesi Veteriner Fakültesi Dergisi,
c. 66,
sayı. 4,
ss.
385-389, Eyl. 2019, doi:10.33988/auvfd.552122
|